XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.2
MEDICARE PART D
 6 Months Ended
Jun. 30, 2022
Insurance [Abstract]  
MEDICARE PART D MEDICARE PART D
We cover prescription drug benefits in accordance with Medicare Part D under multiple contracts with the Centers for Medicare and Medicaid Services, or CMS, as described further in Note 2 to the consolidated financial statements included in our 2021 Form 10-K. The accompanying condensed consolidated balance sheets include the following amounts associated with Medicare Part D at June 30, 2022 and December 31, 2021. CMS subsidies/discounts in the table below include the reinsurance and low-income cost subsidies funded by CMS for which we assume no risk as well as brand name prescription drug discounts for Part D plan participants in the coverage gap funded by CMS and pharmaceutical manufacturers.
 June 30, 2022December 31, 2021
Risk
Corridor
Settlement		CMS
Subsidies/
Discounts		Risk
Corridor
Settlement		CMS
Subsidies/
Discounts
 (in millions)
Other current assets$148 $703 $363 $1,894 
Trade accounts payable and accrued expenses(93)(2,355)(68)(466)
Net current asset (liability)55 (1,652)295 1,428 
Other long-term assets361 — 5 — 
Other long-term liabilities(212)— (194)— 
Net long-term asset (liability)149 — (189)— 
Total net asset (liability)$204 $(1,652)$106 $1,428